Skip to main content

Table 1 Demographic and baseline characteristics of the study cohort divided into patients that received neoadjuvant chemotherapy and radical hysterectomy (NACTRH) or chemo-radiotherapy (CRT)

From: Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2)

  Group
NACTRH
(n = 46)
CRT
(n = 51)
P value
Age, year, Median (SD) 46.41 (10.8) 53.06 (11.02) 0.004
Gravid, Median (IQR) 3 (1–3) 2 (1–3) 0.93
Fallow up time, year, Median (IQR) 3.85 (3.48–4.3) 3.2 (2.8–3.7) < 0.001
Stage, n (%)
IB3 29 (63) 21 (41.2) 0.03
IIA2 17 (37) 30 (58.8)
Surgery complications, n (%) 6 (13) NA
Chemotherapy complications, n (%) 6 (13) 10 (19.6) 0.38
Chemo-radiotherapy complications, n (%) 12 (23.5) NA